Document:

<PAGE>

                                                                    Exhibit 10.5

                  TENDER LOVING CARE HEALTH CARE SERVICES, INC.

                              EMPLOYMENT AGREEMENT
                                      WITH
                                 DAVID SAVITSKY

         AGREEMENT as of the 18th day of October, 2001, between David Savitsky,
residing at 29 Oxford Road, New Rochelle, New York 10804 ("Executive"), and
Tender Loving Care Health Care Services, Inc. ("Company"), a Delaware
corporation, having its principal place of business at 1983 Marcus Avenue, Lake
Success, New York 11042.

                              W I T N E S S E T H:

         WHEREAS, the Company wishes to secure the services of Executive on the
terms and conditions set forth below;

         WHEREAS, Executive is party to an employment agreement with the Company
dated October 20, 1999 ("TLCS Agreement");

         WHEREAS, e-Medsoft.com ("Med") and Company have entered into an
Agreement and Plan of Merger and Reorganization dated as of October 18, 2001
("Merger Agreement") whereby, among other things, Med will acquire all of the
outstanding shares of TLCS (collectively, the "Acquisition");

         WHEREAS, the Acquisition triggers certain rights of Executive under the
TLCS Agreement; and

         WHEREAS, the Executive is willing to accept employment with the Company
on such terms and conditions set forth in this Agreement.

         NOW, THEREFORE, in consideration of the premises and mutual agreements
hereinafter contained, the parties hereto do agree as follows:

         1. EMPLOYMENT. The Company will employ the Executive as Vice Chairman
of Governmental Affairs of the Company in accordance with all of the terms and
conditions set forth in this Agreement.

         2. TERM. The term of Executive's employment under this Agreement shall
commence effective as of the date on which the Minimum Condition (as such term
is defined in the Merger Agreement) has been satisfied (the "Effective Date")
and subject to the terms and conditions of this Agreement, shall continue for a
period of sixty (60) consecutive months. This Agreement shall be automatically
renewed for the sixty (60) month period following each anniversary of the
Effective Date hereof (an "Anniversary Date") unless Executive or the Company
shall have filed an election to terminate, as hereinafter provided, in which
event Employee's employment shall terminate sixty (60) months after the filing
of such election. Such election to terminate shall be made by either Executive
or the Company by notice in writing to the other, on or before the Anniversary
Date of any year of employment, and in such case the effective date of such
election shall be deemed to be the Anniversary Date of such year of employment.

<PAGE>

         3. COMPENSATION AND BONUS PAYMENTS; WARRANTS.

            (a) The Company shall pay to Executive, for all services rendered
by Executive under this Agreement, a base salary at the rate of $120,000 per
year ("Base Salary") payable in equal installments (not less frequently than
monthly) in accordance with the Company's regular payroll practices. On each
Anniversary Date, during the term hereof, the Base Salary shall be increased by
a cost-of-living adjustment of an amount equal to the percentage increase, if
any, of the Consumer Price Index as published by the Bureau of Labor Statistics.

            (b) In addition to Section 3(a) above, Executive will be entitled
to receive a signing bonus in the amount of $2,551,000, less applicable
withholding taxes, on the Effective Date ("Signing Bonus"); provided, however,
if the Executive shall voluntarily terminate employment with the Company (other
than for Good Reason pursuant to Section 9(c)(ii) below) or if the Executive is
terminated for Cause (as defined in Section 9(a) below) during the first twelve
(12) months of the Agreement, the Executive shall immediately pay the Company an
amount equal to $2,551,000 (less applicable withholding taxes that are
refundable or creditable to the Company, if any) multiplied by a fraction, the
numerator of which shall be twelve (12) less the total number of full months
that have elapsed from the Effective Date and the date of termination and the
denominator of which shall be twelve (12).

            (c) Notwithstanding Section 3(b) above, a Change of Control of the
Company or Med shall not cause the Signing Bonus to be fully vested. "Change of
Control" shall be deemed to occur when a person, corporation, partnership,
association or entity (x) acquires a majority of the Company's or Med's
outstanding voting securities, or (y) acquires securities of the Company or Med
bearing a majority of voting power with respect to election of directors of the
Company or Med, or (z) acquires all or substantially all of the Company's or
Med's assets.

            (d) In addition to his Base Salary and Signing Bonus, (a) for a
twelve-month period from the date of this Agreement ("Initial Period"),
Executive shall be entitled to participate in the current existing executive
bonus plan of the Company as adopted by the Board of Directors of the Company;
and (b) after the Initial Period, Executive shall be entitled to participate in
any executive bonus plan maintained by Med.

            (e) As additional consideration for Executive entering into this
Agreement and agreeing to perform his obligations hereunder, Med is issuing to
Executive a Warrant to purchase 2,400,000 shares of common stock of Med, on the
terms and conditions set forth therein.

         4. DUTIES. Executive is engaged to serve as Vice Chairman of
Governmental Affairs of the Company and shall perform such duties and functions
as is compatible with that position as the Company from time-to-time may
determine. During the term of this Agreement, Executive shall be employed on a
part-time basis and shall work as many hours as are reasonably necessary to
perform his obligations hereunder. Executive shall report to the Chief Executive
Officer of the Company.

                                       2
<PAGE>

         5. EXPENSES. Executive is authorized to incur expenses for promoting
the business of the Company which are reasonable and necessary in the exercise
of his duties, including reasonable expenses for entertainment, travel and
similar items. The Company shall reimburse Executive promptly for all such
expenses upon presentation by Executive, from time to time, of an itemized
account of expenditures. The Company shall pay monthly lease payments for one
automobile (of the make and model currently used by Executive in connection with
the Company's business) and shall pay liability and collision insurance, gas and
maintenance with respect to Executive's use thereof, in each case on a basis
consistent with past practice by the Company with respect to Executive.

         6. VACATION. The Executive is entitled to five (5) weeks annual
vacation. If the vacation time is not used within the annual period the
Executive will not be entitled to carry over the unused vacation time.

         7. DEATH OR DISABILITY. In the event Executive becomes disabled, the
Company's obligations hereunder, including Section 3, shall not be affected
thereby, and Executive's duties under Section 4 may be reduced only if, and the
event that, his disability prevents him from fully or completely satisfying any
duty thereunder. In the event of the death of the Executive or termination of
this Agreement upon Executive's disability pursuant to Section 9(d) below, the
Company shall pay Executive, his estate or his designated beneficiary, as the
case may be, the amounts specified in Section 9(d) below.

         8. WELFARE BENEFITS. Executive shall be entitled to continue to receive
or participate in all benefits, such as life, health, medical and disability
plans, profit sharing plans, pension plans and the like ("Welfare Plans"), which
the Company may make generally available to its senior executive employees.
Executive shall be entitled to the above-described benefits so long as Executive
serves as an employee of the Company, or as otherwise provided by the terms and
conditions of the Welfare Plans.

         9. TERMINATION.

            (a) FOR CAUSE. Notwithstanding anything herein to the contrary, the
Company may terminate this Agreement for Cause (as hereinafter defined). The
Company shall furnish a written notice (a "Notice of Cause") to Executive
indicating that the Company intends to terminate this Agreement for Cause, with
such notice to specify in reasonable detail the event(s) or circumstance(s) that
the Company believes constitute Cause for purposes of this Agreement. The date
on which Executive receives such written notice shall be the "Notice Date."
Within 15 days following the Notice Date, Executive shall have the right to
provide the Company a written notice (a "Notice of Dispute") describing any
dispute or disagreement Executive has with the Company regarding the alleged
event(s) or circumstance(s) specified by the Company in its Notice of Cause such
that, in Executive's view, Cause does not then exist for purposes of this
Agreement. If Executive does not deliver a Notice of Dispute to the Company
within such 15-day period, Executive's employment shall be deemed terminated for
Cause as of the Notice Date. If Executive delivers a Notice of Dispute to the
Company during such 15-day

                                       3
<PAGE>

period, the dispute shall be determined by arbitration in accordance with
Section 13 below. During the pendency of any such dispute, Executive's
employment shall continue hereunder and the Company shall continue to pay to
Executive the Base Salary, bonus payments and benefits to which Executive is
entitled hereunder. In the event the arbitrator finally determines that "Cause"
did exist as specified in the Notice of Cause, Executive's employment shall be
deemed terminated for Cause as of the Notice Date. If the Executive's employment
is terminated for Cause, the Company shall pay the Executive only the accrued
and unpaid portions of the Base Salary and any Performance Bonus and other bonus
payments and benefits which have accrued through the date of termination and, to
the extent Executive actually received any Base Salary or bonus payments
allocable to any period from and after the Notice Date, Executive shall pay to
the Company the amount of any such Base Salary or bonus payments, if any,
promptly following the determination in accordance with this Section 9(a) that
Executive's employment has been terminated for Cause. Termination for "Cause"
shall include termination of Executive because of the Executive's personal
dishonesty in the performance of any of his material duties hereunder, willful
misconduct in the performance of any of his material duties hereunder, breach of
fiduciary duty to the Company involving personal profit, intentional failure to
perform stated duties hereunder, willful violation of any law, rule or
regulation constituting a felony or final cease-and-desist order (in each case
as determined by the Board of Directors of the Company, subject to arbitration
under Section 13 hereof, provided that in the event of any such arbitration, the
Company shall be the claimant with the burden of proving the existence of
Cause). In the event Executive is terminated for Cause, Executive shall have no
further rights under this Agreement.

            (b) WITHOUT CAUSE. If the Company terminates the Executive's
employment hereunder without Cause, the Company will make the following payments
to the Executive: (i) the Company shall continue to pay the then-prevailing Base
Salary through the end of the then current 60-month term of this Agreement as if
the Executive had continued to be employed by the Company; (ii) any unpaid bonus
payments, whether or not earned, which shall be paid to Executive in one lump
sum on the termination date; (iii) such benefits as have accrued and are unpaid
as of the termination date under any Welfare Plan in which the Executive is a
participant; and (iv) to the extent applicable, the cost of COBRA-based health
insurance for a period of 12 months after the termination date, payable monthly.

            (c) RESIGNATION. (i) WITHOUT GOOD REASON. If the Executive resigns
his employment other than for Good Reason (as hereinafter defined), the
Executive shall be deemed to have been terminated for Cause and the Company
shall have all of the obligations to the Executive described in subsection (a)
above.

                (ii) WITH GOOD REASON. Notwithstanding the foregoing, if the
Executive resigns for Good Reason, the Executive shall be deemed to have been
terminated without Cause and the Company shall have all of the obligations to
the Employee described in subsection (b) above. For purposes of this Agreement,
"Good Reason" means (i) an assignment by the Company to Executive of duties
which are inconsistent with Executive's title and position with the Company;
(ii) any breach of this Agreement by the Company that has not been cured within
thirty (30) days after written notice to the Chief Executive of Med by Executive
of such breach; (iii) any requirement that Executive relocate his principal
place of business outside of Lake Success, New York, or (iv) any attempt by the
Company to terminate Executive's

                                       4
<PAGE>

employment for Cause where Cause is not proven. Notwithstanding anything to the
contrary herein, Good Reason shall not mean an election by the Company to
terminate this Agreement pursuant to Section 2 hereof.

            (d) DEATH OR DISABILITY. This Agreement shall terminate
automatically upon Executive's death. Company may terminate Executive's
employment hereunder upon Executive's inability to substantially perform his
duties hereunder by reason of illness or incapacity for an aggregate of ninety
(90) consecutive days or total of one hundred eighty (180) days in any twelve
(12) month period. Upon termination of this Agreement for death or disability,
Executive or his estate or designated beneficiary shall be entitled to (i) his
Base Salary through the end of the then current 60-month term; (ii) any unpaid
bonus payments, whether or not earned, which shall be paid to Executive in one
lump sum on the termination date; and (iii) such benefits as have accrued and
are unpaid as of the termination date under any Welfare Plan in which the
Executive is a participant;

         10. FAILURE TO PERFORM OBLIGATIONS. Executive shall be under no
obligation to minimize or mitigate damages by seeking other employment or
otherwise in the event the Company breaches or does not fulfill its obligations
under this Agreement. It is further agreed that in the event of a default by the
Company, without a violation of this Agreement by the Executive, of its
obligations under this Agreement or of an unsuccessful action by the Company
against Executive for his alleged violation of this Agreement, Executive shall
be entitled to recover from the Company all his expenses of enforcing or
defending any action arising out of this Agreement, including his reasonable
legal fees and expenses.

         11. CONFIDENTIALITY. Executive shall hold in a fiduciary capacity for
the benefit of the Company all secret or confidential information, knowledge or
data relating to the Company, and its business, which shall have been obtained
by Executive during Executive's employment by the Company or at any time prior
thereto and which shall not be or become public knowledge (other than by acts by
Executive or representatives of Executive in violation of this Agreement). After
termination of Executive's employment with the Company, Executive shall not,
without the prior written consent of the Company or as may otherwise be required
by law or legal process, communicate or divulge any such information, knowledge
or data to anyone other than the Company and those designated by it.

         12. NONCOMPETITION BY EXECUTIVE.

             (a) Upon termination of Executive's employment hereunder for any
reason, Executive agrees not to compete, in the manner described hereinafter,
with the business currently conducted by the Company in the United States, for a
period of six (6) months following such termination. Executive agrees that,
during such period, he will not be employed by, work for, advise, consult with,
serve or assist in any way, directly or indirectly, any party whose activities
or business is similar to that of the Company. The foregoing restrictions on
competition by Executive shall be operative for the benefit of the Company and
of any business owned or controlled by the Company, or any successor or assign
of any of the foregoing.

             (b) If the period of time or geographical areas specified under
this section should be determined to be unreasonable in any judicial proceeding,
then the period of time and areas of the restriction shall be reduced so that
this Agreement may be enforced in such areas and during such period of time as
shall be determined to be reasonable.

                                       5
<PAGE>

         13. ARBITRATION. The Executive and Company hereby agree that if any
dispute arises between them, such dispute shall be determined by arbitration in
the State of New York in accordance with the rules of the American Arbitration
Association then in effect. The award rendered by such arbitration shall be
final and binding upon the parties hereto, and a judgment upon the award so
rendered may be entered in any court of competent jurisdiction. For any such
arbitration, the Company shall pay the costs of the arbitrator in connection
therewith and the prevailing party in such dispute shall be reimbursed by the
other party for all of the prevailing party's legal fees and expenses and other
out-of-pocket costs incurred in connection with the dispute.

         14. WAIVER. Failure to insist upon compliance with any of the terms,
covenants, or conditions hereof shall not be deemed a waiver of such term,
covenant, or condition, nor shall any waiver or relinquishment of any right or
power hereunder at any one time or more times be deemed a waiver or
relinquishment of such right or power at any other time or times.

         15. SEVERABILITY. The invalidity or unenforceability of any provision
hereof shall in no way affect the validity or enforceability of any other
provision. The parties to this Agreement agree and intend that this Agreement
shall be enforced as fully as it may be enforced consistent with applicable
statutes and rules of law.

         16. BENEFIT. Except as otherwise herein expressly provided, this
Agreement shall inure to the benefit of and be binding upon the Company, its
successors and assigns, including, without limitation, any corporation which may
acquire all or substantially all of the Company's assets or business or with or
into which the Company may be consolidated or merged, and to the benefit of, and
be binding upon, Executive, his heirs, executors, administrators and legal
representatives.

         17. ENTIRE AGREEMENT. This Agreement constitutes the entire
understanding and agreement between the parties hereto, supersedes any and all
prior discussions, agreements and correspondence with regard to the subject
matter hereof, and may not be amended, modified or supplemented in any respect,
except by a subsequent writing executed by both parties hereto.

         18. APPLICABLE LAW. This Agreement shall be governed by, and construed
and enforced in accordance with, the laws of the State of New York, without
giving effect to principles of conflicts of law.

         19. REMEDY FOR BREACH. Any action to enforce, arising out of, or
relating in any way to, any of the provisions of this Agreement shall be an
action at law pursuant to the provisions of Section 13 of this Agreement.

         20. NOTICES. All notices required hereby or given under this Agreement
shall be in writing and shall be served either personally or by certified mail,
return receipt requested, at the following addresses, or at such other address
as the parties may designate to one another in writing:

                                       6
<PAGE>

                  To the Company:   1983 Marcus Avenue
                                    Lake Success, New York 11042
                                    Attn: Chief Executive Officer

                  With a copy to:   E-MEDSOFT.COM
                                    650 Suffolk Street
                                    Lowell, Massachusetts 01854

                  To Executive:     David Savitsky
                                    29 Oxford Road
                                    New Rochelle, New York 10804

All notices shall be deemed given when so received. All change of address
notices shall be given in the same manner as provided above.

         21. WAIVER OF RIGHTS UNDER PRIOR AGREEMENTS. By executing this
Agreement but conditioned on this Agreement become effective on the Effective
Date as provided in Section 2 above, the Executive fully releases, acquits and
forever discharges the Company, and all of its former or current respective
subsidiaries of and from any and all claims, actions, causes of action, charges,
judgments, grievances, obligations, rights, demands, debts, sums of money,
wages, overtime, commissions, bonuses, stock payments, dividends, damages,
attorney's fees, costs, losses, liabilities or accountings of whatever nature,
whether known or unknown, disclosed or undisclosed, asserted or unasserted, in
law or equity, contract or tort or otherwise, arising out of the TLCS Agreement,
including, but not limited to, any rights to severance payments.

         22. COUNTERPARTS. This Agreement may be executed in one or more
original or facsimile counterparts.

                            [signature page follows]

                                       7
<PAGE>

         IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date first above written.

                         TENDER LOVING CARE HEALTH CARE SERVICES,
                         INC.

                         By:  /s/ STEPHEN SAVITSKY
                              ----------------------------------------
                              Stephen Savitsky
                              Chairman of the Board and Chief Executive Officer

                         EXECUTIVE

                              /s/ DAVID SAVITSKY
                         ------------------------------------------------------

                         WITNESS

                              /s/ WILLARD T. DERR
                         ------------------------------------------------------

                                       8<PAGE>

                                                                  Exhibit 10.6

THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OR CONVERSION
HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR APPLICABLE
STATE SECURITIES LAWS AND HAVE BEEN TAKEN FOR INVESTMENT PURPOSES ONLY AND NOT
WITH A VIEW TO THE DISTRIBUTION THEREOF, AND SUCH SECURITIES MAY NOT BE SOLD,
OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED UNLESS THERE IS
AN EFFECTIVE REGISTRATION STATEMENT COVERING SUCH SECURITIES OR E-MEDSOFT.COM
(THE "COMPANY") RECEIVES AN OPINION OF COUNSEL (WHICH MAY BE COUNSEL FOR THE
COMPANY) STATING THAT SUCH SALE OR TRANSFER IS EXEMPT FROM THE REGISTRATION AND
PROSPECTUS DELIVERY REQUIREMENTS OF SUCH ACT OR APPLICABLE STATE SECURITIES
LAWS.

                                  e-MedSoft.com

              Warrant to Purchase 6,000,000 Shares of Common Stock
                         Date of Grant: October 18, 2001
                           Void After October 18, 2006

     e-MedSoft.com, a Nevada Corporation (the "COMPANY") hereby certifies that,
for value received, Stephen Savitsky (the "HOLDER") is the registered holder of
a warrant ("WARRANT") to subscribe for and purchase from the Company, at the
Warrant Price defined in Section 2 herein, six million (6,000,000) fully paid
and non-assessable shares of the Company's common stock. $0.001 par value per
share (the "COMMON STOCK"), such price and such number of shares being subject
to adjustment upon occurrence of the contingencies set forth in this Warrant
("WARRANT SHARES").

     This Warrant is subject to the following terms and conditions:

     1. TERM/VESTING OF WARRANT.

     (a) Subject to Section 1(b) hereof, this Warrant may be exercised in whole
or in part at any time prior to the first to occur of the following: (i) 5:00
p.m., Pacific Standard Time, October 18, 2006; or (ii) the consummation of any
transaction or series of transactions (collectively, the "TRANSACTION"),
including without limitation, the sale, transfer or disposition of all or
substantially all of the Company's assets or the merger of the Company with or
into, or consolidation with, any other corporation, whereby the holders of the
Company's voting securities prior to the Transaction do not hold more than 50%
of the voting securities of the surviving entity following consummation of the
Transaction (a "CHANGE OF CONTROL").

     Upon the occurrence of any of the events described in clause (i) above,
this Warrant, to the extent not exercised, shall terminate. Upon the occurrence
of any of the events described in clause (ii) above, this Warrant, to the extent
not otherwise exercisable or previously exercised, shall be deemed to have been
automatically become exercisable in full and converted pursuant to

<PAGE>

Section 4 hereof and thereafter the Holder shall participate in the Transaction
on the same terms as other holders of Common Stock.

     (b) This Warrant shall not be exercisable until 90 days after the close of
the Minimum Condition (as that term is defined in the Agreement and Plan of
Merger and Reorganization ("Merger Agreement") by and among the Company, TLC
Acquisition Corporation, and Tender Loving Care Health Care Services, Inc.
("TLCS"); provided, however, if the Executive shall voluntarily terminate
employment with TLCS (other than for Good Reason) or if the Executive is
terminated for Cause (as such terms are defined in the Employment Agreement
dated October 18, 2001 by and between Holder and TLCS ("EMPLOYMENT AGREEMENT"))
during the first twelve (12) months of the Employment Agreement, the Executive
shall immediately return to the Company a number of shares equal to the Warrant
Shares multiplied by a fraction, the numerator of which shall be twelve (12)
less the total number of full months that have elapsed from the Effective Date
(as such term is defined in the Employment Agreement) and the date of
termination and the denominator of which shall be twelve (12).

     2. WARRANT PRICE.

     The exercise price of this Warrant (the "WARRANT PRICE") shall equal $0.50
per share.

     3. METHOD OF EXERCISE; PAYMENT; ISSUANCE OF NEW WARRANT. Subject to Section
1 hereof, the purchase right represented by this Warrant may be exercised by the
holder hereof, in whole or in part and from time to time, by the surrender of
this Warrant (with the notice of exercise form attached hereto as Exhibit A duly
executed) at the principal office of the Company and by the payment to the
Company of an amount equal to the Warrant Price multiplied by the number of
Warrant Shares then being purchased. The person or persons in whose name(s) any
certificate(s) representing shares of Common Stock are issuable upon exercise of
this Warrant shall be deemed to have become the holder(s) of record of, and
shall be treated for all purposes as the record holder(s) of, the shares
represented thereby (and such shares shall be deemed to have been issued)
immediately prior to the close of business on the date or dates upon which this
Warrant is exercised. In the event of any exercise of the rights represented by
this Warrant, certificates for the shares of Common Stock so purchased shall be
delivered to the holder hereof as soon as possible and in any event within 15
days after such exercise and, unless this Warrant has been fully exercised, the
portion of the Warrant Shares, if any, with respect to which this Warrant shall
not then have been exercised shall also be issued to the holder hereof as soon
as possible and in any event within such 15-day period.

     4. RIGHT TO CONVERT WARRANT INTO COMMON STOCK; NET ISSUANCE.

     (a) RIGHT TO CONVERT. In addition to and without limiting the rights of a
holder of this Warrant under the terms hereof, a holder shall have the right to
convert this Warrant or any portion thereof (the "CONVERSION RIGHT") into shares
of Common Stock as provided in this Section 4 at any time or from time to time
during the period during which this Warrant is exercisable pursuant to the terms
hereof. Upon exercise of the Conversion Right with respect to all or a specified
portion of shares subject to this Warrant (the "CONVERTED WARRANT SHARES"), the
Company shall deliver to the holder (without payment by the holder of any

                                       2
<PAGE>

exercise price or any cash or other consideration) that number of shares of
fully paid and nonassessable Common Stock equal to the quotient obtained by
dividing (x) the value of this Warrant (or the specified portion hereof) on the
Conversion Date (as defined in Section 4(b) below), which value shall be equal
to (A) the aggregate fair market value of the Converted Warrant Shares issuable
upon exercise of this Warrant (or the specified portion hereof) on the
Conversion Date less (B) the aggregate of the Warrant Price applicable to the
Converted Warrant Shares immediately prior to the exercise of the Conversion
Right by (y) the fair market value of one share of Common Stock on the
Conversion Date. Expressed as a formula, such conversion shall be computed as
follows:

                   X=    A-B
                         ---
                          Y

         Where:    X=    the number of shares of Common Stock that may be
                         issued to the holder

                   Y=    the fair market value (FMV) of one share of Common
                         Stock

                   A=    the aggregate FMV (I.E., FMV x Converted Warrant
                         Shares)

                   B=    the aggregate Warrant Price (I.E., Converted Warrant
                         Shares x Warrant Price)

     No fractional shares shall be issuable upon exercise of the Conversion
Right, and, if the number of shares to be issued determined in accordance with
the foregoing formula is other than a whole number, the Company shall pay to the
holder an amount in cash equal to the fair market value of the resulting
fractional share on the Conversion Date. For purposes of Section 4(a), shares
issued pursuant to the Conversion Right shall be treated as if they were issued
upon the exercise of this Warrant.

     (b) METHOD OF EXERCISE. The Conversion Right may be exercised by the holder
by the surrender of this Warrant at the principal office of the Company together
with a written statement specifying that the holder thereby intends to exercise
the Conversion Right and indicating the number of shares subject to this Warrant
which are being surrendered (referred to in Section 4(a) hereof as the Converted
Warrant Shares), and the Warrant Price applicable thereto, in exercise of the
Conversion Right. Such conversion shall be effective upon receipt by the Company
of this Warrant together with the aforesaid written statement, or on such later
date as is specified therein (the "CONVERSION DATE"). Certificates for the
shares issuable upon exercise of the Conversion Right and, if applicable, a new
warrant evidencing the balance of the shares remaining subject to this Warrant,
shall be issued as of the Conversion Date and shall be delivered to the holder
within 15 days following the Conversion Date

                                       3
<PAGE>

     (c) DETERMINATION OF FAIR VALUE. For purposes of this Section 4, fair
market value of a Share and of a Converted Warrant Share as of a particular date
shall be determined as follows:

          (a) if such Share is then quoted on The American Stock Exchange, any
     other national securities exchange, Nasdaq, or the OTC Bulletin Board, the
     simple average of the closing sales prices as reported on such exchange or
     market for the ten (10) consecutive trading days prior to such date;

          (b) if such share is publicly traded but is not quoted on The American
     Stock Exchange, any other national securities exchange, Nasdaq nor the OTC
     Bulletin Board, the value shall be the fair market value thereof, as
     determined in good faith by the Board of Directors of the Company.

     5. STOCK FULLY PAID; RESERVATION OF SHARES. All Warrant Shares that may be
issued upon the exercise of the rights represented by this Warrant shall, upon
issuance pursuant to the terms and conditions herein, be fully paid and
nonassessable, and free from all taxes, liens, charges and pre-emptive rights
with respect to the issue thereof. The Company shall pay all transfer taxes, if
any, attributable to the issuance of the Warrant Shares upon the exercise of
this Warrant. Notwithstanding anything to the contrary herein, prior to the
issuance of any Warrant Shares to the Holder, the Company shall be entitled to
withhold any applicable taxes, including adjusting the number of Warrant Shares
issued to reflect such withholding. During the period within which the rights
represented by this Warrant may be exercised, the Company shall at all times
have authorized, and reserved for the purpose of issuance upon exercise of the
purchase rights evidenced by this Warrant a sufficient number of shares of its
Common Stock to provide for the exercise of the rights represented by this
Warrant.

     6. ADJUSTMENT OF PURCHASE PRICE AND NUMBER OF SHARES; LIMITATION ON
EXERCISE. The number and kind of securities purchasable upon the exercise of
this Warrant and the Warrant Price shall be subject to adjustment from time to
time in accordance with this Section 6; provided that, no such adjustment shall
be made if a corresponding adjustment is made pursuant to the Company's Articles
of Incorporation.

     (a) RECLASSIFICATION, CONSOLIDATION OR MERGER. In case of any
reclassification or change of outstanding securities of the class issuable upon
exercise of this Warrant (other than as a result of a subdivision or
combination), or in case of any consolidation or merger of the Company with or
into another corporation (other than a Change of Control as provided in Section
1(b) hereof), the Company, or such successor corporation, as the case may be,
shall execute a new Warrant, providing that the holder of this Warrant shall
have the right to exercise such new Warrant and procure upon such exercise in
lieu of each share of Common Stock theretofore issuable upon exercise of this
Warrant the kind and amount of shares of stock, other securities, money and
property receivable upon such reclassification, change, consolidation or merger
by a holder of one share of Common Stock. Such new Warrant shall provide for
adjustments which shall be as nearly equivalent as may be practicable to the
adjustments provided for in this Section 6. The provisions of this subsection
(a) shall similarly apply to successive reclassifications, changes,
consolidations and mergers.

     (b) SUBDIVISION OR COMBINATION OF SHARES. If at any time on or after the
date of this Warrant the Company shall subdivide its outstanding shares of
Common Stock into a greater number of shares, the Warrant

                                       4
<PAGE>

Price in effect immediately prior to such subdivision shall subdivide its
outstanding shares of Common Stock into a greater number of shares, the Warrant
Price in effect immediately prior to such subdivision shall be proportionately
reduced and the number of shares receivable upon exercise of the Warrant shall
be proportionately increased; and, conversely, if at any time on or after the
date of this Warrant the outstanding number of shares of Common Stock shall be
combined into a smaller number of shares, the Warrant Price in effect
immediately prior to such combination shall be proportionately increased and the
number of shares receivable upon exercise of the Warrant shall be
proportionately decreased.

     (c) ADJUSTMENT OF NUMBER OF SHARES. Upon each adjustment in the Warrant
Price, the number of Shares of Common Stock purchasable hereunder shall be
adjusted, to the nearest whole share, to the product obtained by multiplying the
number of Shares purchasable immediately prior to such adjustment in the Warrant
Price by a fraction, the numerator of which shall be the Warrant Price
immediately prior to such adjustment and the denominator of which shall be the
Warrant Price immediately thereafter.

     7. FRACTIONAL SHARES. No fractional shares of Common Stock will be issued
in connection with any exercise hereunder, but in lieu of such fractional shares
the Company shall make a cash payment therefor based on the fair market value
(as determined in accordance with Section 4(c) hereof) of a share of Common
Stock on the date of exercise.

     8. NOTICES.

     (a) Upon any adjustment of the Warrant Price and any increase or decrease
in the number of shares of Common Stock purchasable upon the exercise of this
Warrant, then, and in each such case, the Company, within thirty (30) days
thereafter, shall give written notice thereof to the registered holder of this
Warrant (the "NOTICE"). The Notice shall be mailed to the address of such as
shown on the books of the Company, and shall state the Warrant Price as adjusted
and the increased or decreased number of shares purchasable upon the exercise of
this Warrant, setting forth in reasonable detail the method of calculation of
each.

     (b) In the event that the Company shall propose at any time to effect a
Change of Control, the Company shall send to the Holder at least 15 days' prior
written notice of the date when the same shall take place.

     (c) Each such written notice shall be given by first class mail, postage
prepaid, addressed to the Holder at the address as shown on the books of the
Company for the Holder.

     9. RESTRICTIONS ON TRANSFER. Certificates representing any of the Common
Stock acquired pursuant to the provisions of this Warrant shall have endorsed
thereon legends substantially in the following form, as appropriate.

     (a) Unless such shares of Common Stock are received in a transaction
registered under the Securities Act and qualified (if necessary) under
applicable state securities laws:

                  "THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED
         FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
         1933. SUCH SHARES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH
         REGISTRATION UNLESS THE

                                       5
<PAGE>

         COMPANY RECEIVES AN OPINION OF COUNSEL REASONABLY ACCEPTABLE TO IT
         STATING THAT SUCH SALE OR TRANSFER IS EXEMPT FROM THE REGISTRATION AND
         PROSPECTUS DELIVERY REQUIREMENTS OF SAID ACT."

     (b) Any legend required to be placed thereon by any applicable state
securities laws.

     10. VOLUME LIMITATIONS ON RESALE. In addition to any restrictions and
limitations imposed by applicable law on the resale of Warrant Shares, Holder
agrees that for a period of five (5) years following the earliest to occur of
either of the events described in Section 1(a) to refrain from selling any
Warrant Shares in excess of 50,000 shares per trading day, and in the event the
closing sales price of the Common Stock for any trading day is below $2.00 per
share, the Holder shall not sell more than 25,000 shares for the next immediate
trading day. Notwithstanding anything to the contrary herein, any sales shall be
subject to Rule 144 of the Securities Act of 1933, as amended, if applicable.

     11. COMPLIANCE WITH ACT. The Holder, by acceptance hereof, agrees that this
Warrant and the Common Stock to be issued upon the exercise or conversion hereof
are being acquired solely for its own account and not as a nominee for any other
party and not with a view toward the resale or distribution thereof and that it
will not offer, sell or otherwise dispose of this Warrant or any of the Common
Stock to be issued upon the exercise or conversion hereof except in accordance
herewith and under circumstances which will not result in a violation of the
Securities Act or of applicable state securities laws.

12. REGISTRATION RIGHTS. Within 90 days after the close of the Minimum Condition
(as that term is defined in the Merger Agreement), the Company shall file a
registration statement under applicable securities laws regarding the shares of
Common Stock underlying the Warrant, to the extent required to permit the
disposition of such shares by Holder pursuant to such registration statement.
The Company shall use its best efforts to respond to any comments received by it
from applicable securities regulations. The Company shall cause such
registration statement to remain effective until the second anniversary of the
date on which all shares of Common Stock underlying the Warrant have been
exercised. The Company shall pay all reasonable expenses of Holder incurred in
connection with the registration of such shares, other than underwriting
discounts and commissions, if any, and applicable transfer or withholding taxes,
if any.

     13. MISCELLANEOUS.

     (a) The terms of this Warrant shall be binding upon and shall inure to the
benefit of any successors or assigns of the Company and of the holder or holders
hereof and of the Common Stock issued or issuable upon the exercise hereof
(including without limitation the estate, heirs or designated beneficiaries of
Holder).

     (b) No holder of this Warrant, as such, shall be entitled to vote or
receive dividends or be deems to be a stockholder of the Company for any
purpose, nor shall anything contained in this Warrant be construed to confer
upon the holder of this Warrant, as such, any rights of a

                                       6
<PAGE>

stockholder of the Company or any right to vote, give or withhold consent to any
corporate action, receive notice of meetings, receive dividends or subscription
rights, or otherwise.

     (c) Receipt of this Warrant by the holder hereof shall constitute
acceptance of and agreement to the foregoing terms and conditions.

     (d) The Company will not, by amendment of its Restated Certificate of
Incorporation or through any other means, avoid or seek to avoid the observance
or performance of any of the terms of this Warrant, but will at all times in
good faith assist in the carrying out of all such terms and in the taking of all
such action as may be necessary or appropriate in order to protect the rights of
the holder of this Warrant against impairment.

     (e) Upon receipt of evidence reasonably satisfactory to the Company of the
loss, theft, destruction or mutilation of this Warrant and, in the case of any
such loss, theft or distribution, upon delivery of an indemnity agreement
reasonably satisfactory in form and amount to the Company or, in the case of any
such mutilation, upon surrender and cancellation of such Warrant, the Company at
its expense will execute and deliver, in lieu thereof, a new Warrant of like
date and tenor.

     (f) This Warrant shall be nontransferable, other than pursuant to (i) a
transfer not involving a change in beneficial ownership, and (ii) any transfer
by any Holder to (A) members of Holder's immediate family or their respective
ancestors or descendants or a trust, custodianship, partnership or fiduciary
account for the benefit of any such person or (B) any foundation organized for
charitable or not-for-profit purposes, in each case for clauses (A) and (B)
whether or not Holder maintains the power to direct any investment decisions.
Any transfer pursuant to this Section 13(f) shall be subject to the terms and
conditions of this Warrant and any applicable securities laws.

     (g) This Warrant or any provision of this Warrant may be amended, waived,
discharged or terminated by a statement in writing signed by the party against
which enforcement of the amendment, waiver, discharge or termination is sought.

     (h) This Warrant shall be governed by the laws of the State of Nevada

                                   E-MEDSOFT.COM

                                   By: /S/ FRANK MAGLIOCHETTI
                                      -----------------------------------------
                                       Name:  Frank Magliochetti
                                       Title: President and Co-CEO

                             Dated: October 18, 2001

                                       7
<PAGE>

                               NOTICE OF EXERCISE

To:  e-MedSoft.com

     1. The undersigned hereby irrevocably elects to purchase ______ shares of
Common Stock of e-MedSoft.com pursuant to the terms of the attached Warrant and
tenders herewith payment of the purchase price of such shares in full.

     2. Please issue a certificate or certificates representing said shares in
the name of the undersigned (or in such other name or names as are specified
below):

Name:________________________________________________________________________
                                 (Please print)

Address:______________________________________________________________________

     3. The undersigned represents that the aforesaid shares are being acquired
for the account of the undersigned for investment and not with a view to, or for
resale in connection with the distribution thereof and that the undersigned has
no present intention of distributing or reselling such shares.

Signature:__________________________________
Date:     __________________________________

                                 ASSIGNMENT FORM

FOR VALUE RECEIVED, ___________________ hereby sells, assigns and transfers unto

Name:________________________________________________________________________
                                 (Please print)

Address:______________________________________________________________________
the right to purchase Common Stock represented by this Warrant to the extent
of __________ shares as to which such right is exercisable and does hereby
irrevocably constitute and appoint ______________________ Attorney, to transfer
the same on the books of e-Medsoft.com corporation with full power of
substitution in the premises.

Dated:__________________________
Signature:_____________________________________________________________________
Witness:______________________________________________________________________
          (Signature must conform to the name of the holder of the Warrant.)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00030-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00030-of-00352.parquet"}]]